Robert Luo is a Director of Chemistry at Accutar Biotech. Colleagues describe him as "I was personally responsible for bringing Robert to Cara Therapeutics, where he was a member of a small group that established the Medicinal Chemistry department. In my experience, he was highly productive, making positive contributions to virtually every project we were involved in at Cara, from early discovery through to preclinical development. Robert is uniquely intuitive and has an innate feel for which molecules to make next, frequently resulting in key breakthroughs. He would be a strong asset to any drug discovery operation, and I recommend him without reservation." and "Robert was a founding member of Fluorous Technologies, Inc. His pioneering work with Prof. Dennis Curran on Fluorous Solid Phase Extractiong (FSPE), fluorous allytin reagents, and fluorous Boc protecting group laid the foundation for the development of Light Fluorous Chemistry. He demonstrated that mixtures of compounds with different number of fluorine atoms could be separated by fluorous HPLC. This technique has been applied to Fluorous Mixture Synthesis of natural product analogs and published in a Science paper. It was highlighted by C&EN as one of four significant major developments in organic chemistry in 2001. Robert is a passionate organic chemist. He demonstrated his creative problem solving capability in numerous cases. He is also a very productive and hard working scientist and a good team player. I have no reservation to recommend Robert for any challenging research positions, and I am confident his performance will exceed the job expectation."